363 studies found for:    Spasticity
Show Display Options
Rank Status Study
21 Suspended Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs
Condition: Muscle Spasticity
Intervention: Other: No Intervention
22 Completed Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: arbaclofen;   Drug: baclofen;   Drug: Placebo
23 Unknown  Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Conditions: Basal Energy Expenditure;   Spasticity
Intervention: Other: Weaning of Antispasticity Medication
24 Unknown  A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
Condition: Spasticity
Intervention:
25 Completed
Has Results
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
26 Recruiting Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia
Conditions: Spasticity;   Focal Dystonia;   Tremor, Limb
Interventions: Device: E-stim;   Device: Ultrasound
27 Active, not recruiting One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity
Conditions: Multiple Sclerosis;   Spasticity
Intervention: Drug: arbaclofen
28 Recruiting Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Crossover RCT
Conditions: Spasticity;   Cerebral Palsy
Interventions: Device: shock waves;   Drug: Botulinum Toxin Type A
29 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
Condition: Muscle Spasticity
Interventions: Drug: tolperisone HCl (AV650);   Drug: Placebo
30 Recruiting Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients
Conditions: Muscle Spasticity;   Multiple Sclerosis
Interventions: Biological: incabotulinumtoxinA;   Biological: Placebo
31 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
Condition: Muscle Spasticity
Intervention: Drug: tolperisone HCl
32 Completed Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
Conditions: Mental Retardation;   Spasticity
Intervention:
33 Completed Physiologic Studies of Spasticity
Conditions: Muscle Spasticity;   Healthy
Intervention:
34 Recruiting Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity
Condition: Spasticity
Interventions: Device: repetitive Transcranial Magnetic Stimulation (rTMS);   Device: Sham repetitive Transcranial Magnetic Stimulation
35 Recruiting Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy
Conditions: Cerebral Palsy;   Spasticity
Interventions: Drug: IncobotulinumtoxinA (8 Units per kg body weight);   Drug: IncobotulinumtoxinA (6 Units per kg body weight);   Drug: IncobotulinumtoxinA (2 Units per kg body weight)
36 Recruiting Action of Baclofen Capsules in Spasticity Due to Multiple Sclerosis
Condition: Spasticity
Interventions: Drug: Baclofen dose 1;   Drug: Baclofen dose 2;   Drug: Placebo
37 Enrolling by invitation Efficacy and Cost-effectiveness of Spasticity Treatment With Multifocal TENS
Conditions: Spasticity;   Stroke;   Cerebral Palsy
Intervention: Device: Multifocal TENS garment (Mollii®)
38 Recruiting The Effect of Whole Body Vibration on Spasticity in Persons With Spinal Cord Injury
Conditions: Spinal Cord Injury;   Spasticity
Intervention: Device: Vibration with tilt-table standing
39 Active, not recruiting Long-term Surveillance of the MedStream Programmable Infusion System
Condition: Spasticity
Intervention: Device: MedStream Programmable Infusion System
40 Completed Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
Conditions: Multiple Sclerosis;   Muscle Spasticity;   Spinal Cord Injury;   Stroke
Intervention: Drug: tizanidine hydrochloride capsule

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years